Skip to content

Improving Mind/Body Health and Functioning With Integrative Exercise

Improving Mind/Body Health and Functioning With Integrative Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02856412
Enrollment
84
Registered
2016-08-04
Start date
2017-09-04
Completion date
2023-02-01
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Disorders, Post-Traumatic

Keywords

Stress Disorders, Post-Traumatic, Exercise, Mindfulness

Brief summary

There is evidence demonstrating that aerobic exercise improves many symptoms of Posttraumatic Stress Disorder (PTSD) including; anxiety, depression, insomnia, and cognition. With the goal of using exercise as a rehabilitation therapy for Veterans with PTSD, a team of scientists and doctors developed a 12-week exercise program, combining aerobic and strength training with concentration training and mindful breathing techniques. The initial pilot study suggested that Integrative Exercise may improve overall quality of life, sleep quality, cardiovascular fitness, and PTSD symptoms. This new study will help determine the effectiveness of Integrative Exercise compared to health education classes. The overall goal is to determine if integrative exercise is an effective rehabilitation intervention for combat Veterans with PTSD.

Detailed description

Despite the considerable efforts of the VA to improve awareness of mental health problems and access to care, many returning Veterans still report substantial barriers to seeking traditional mental health care. There is a large body of evidence demonstrating that aerobic exercise effectively improves many outcomes relevant to Posttraumatic Stress Disorder (PTSD) including; anxiety, depression, insomnia, cognition, and cardiovascular disease. In addition, there is a rapidly growing evidence base showing that aerobic exercise produces an increase in the growth of new neurons (e.g., neurogenesis) and increases the volume of the hippocampus which underscores the potential value of exercise for producing broad benefits to psychological health. Recognizing the promise that exercise might hold for attracting more Veterans into care and improving overall health in Veterans with PTSD, a team of investigators at the San Francisco Veterans Administration Medical Center (SFVAMC) with funding from the Department of Defense developed a treatment protocol and completed a pilot study of Integrative Exercise (Aerobic exercise and Breath Training 3 weekly sessions over 12 weeks) versus a waitlist control condition. Promising results from this trial have led us to the next step which is to conduct a definitive efficacy study of Integrative Exercise versus an active health education control condition: Illness Management and Recovery (IMR). The control condition will be matched on contact hours with treatment personnel. The goal of this revised proposal is to test if Integrative Exercise improves overall quality of life, PTSD symptoms, sleep quality, and measures of cardiovascular health in combat Veterans with chronic PTSD relative to the IMR condition. Another goal is to test if improvements in quality of life are predicted by improvements in cardiovascular fitness as measured by exercise capacity on treadmill testing. Finally, the proposal will test if Integrative Exercise versus IMR will produce greater improvements in additional health outcomes, including mood, subjective sleep quality, and PTSD symptoms.

Interventions

OTHERVeterans Group Exercise (VGX)

Integrative Exercise incorporates elements of strength training, flexibility, cardiovascular training, and controlled breathing exercises.

Illness Management and Recovery is an educational program focused on helping individuals more effectively manage their illnesses to pursue their personal recovery goals. The classes include the following topic areas which have been adapted for use in PTSD: recovery, practical facts about PTSD, stress-vulnerability, building social support, medications for PTSD, drug and alcohol use, reducing relapse, coping with stress, coping with persistent symptoms, getting needs met in the VA healthcare system, and living a healthy lifestyle.

Sponsors

University of California, San Francisco
CollaboratorOTHER
VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Veterans (Male and Female) between the ages of 18-75 who are physically able to participate in an exercise program * Meet criteria for PTSD of at least 3 months duration, OR have some symptoms of PTSD with a current CAPS score of 23 or higher, as indexed by the Clinician Administered PTSD Scale for DSM-5 (CAPS-5)

Exclusion criteria

* History of any psychiatric disorder with active psychosis or mania in the past 5 years * Meet criteria for severe drug or alcohol use disorder within the past 6 months as assessed by the Structured Clinical Interview for DSM-5 * Prominent suicidal or homicidal ideation * Currently exposed to recurrent trauma or have been exposed to a traumatic event within the past 3 months * Pregnant * Have a clinically significant: * neurologic disorder * systemic illness affecting central nervous system (CNS) function * history of seizure disorder in the past 5 years * and/or physical disabilities making it impossible to use exercise equipment * Acute coronary events (i.e., Myocardial Infarction) in the past 6 months * Moderate to severe Traumatic Brain Injury (any history of head trauma associated with the onset of persistent cognitive complaints, neurological symptoms, or loss of consciousness \> 30 minutes) * Subjects who, in the opinion of the investigator, are otherwise unsuitable for a study of this type * The investigators will not exclude patients with PTSD who are currently receiving individual or group therapy or patients who are currently taking antidepressant or anti-anxiety medication, but will apply the following criteria: * patients must have been in treatment for at least 2 months * meet symptomatic criteria for inclusion * do not have plans to discontinue treatment during the course of the trial

Design outcomes

Primary

MeasureTime frameDescription
Clinician Administered PTSD Scale (CAPS) Score Comparison Between Subjects Randomized to Integrative Exercise Treatment vs. Illness Management and Recovery12 weeksThe CAPS-5 is a 20 item scale that provides both a dimensional and categorical measure of PTSD. The CAPS-5 items are rated with a single severity score, ranging from 0-80 with higher scores indicating worse severity, that incorporates both frequency and intensity PTSD-related symptoms. In addition to assessing the 20 DSM-5 PTSD symptoms, questions target the onset and duration of symptoms, subjective distress, impact of symptoms on social and occupational functioning, improvement in symptoms since a previous CAPS administration, overall response validity, overall PTSD severity, and specifications for the dissociative subtype (depersonalization and derealization).
The World Health Organization Quality of Life (WHOQOL-BREF) Score Comparison Between Subjects Randomized to Integrative Exercise Treatment vs. Monitor Only12 weeksThe WHOQOL-BREF instrument comprises 26 items, which measure the following broad domains: physical health, psychological health, social relationships, and environment. The WHOQOL-BREF is a shorter version of the original WHOQOL-100 instrument and is more convenient for use in large research studies or clinical trials. The Psychological Domain, the investigators' primary outcome, is derived from 6 items which index body image, negative & positive feelings, self-esteem, spirituality, and cognition. Each of the 6 items have 5 response options with higher scores indicating higher psychological health. The mean score of items within each domain is used to calculate the domain score. The domain score is then linearly transformed to scale of 0-100 to enable comparisons between other domains composed of unequal numbers of items. (Skevington et al. Quality of Life Research 13: 299-310, 2004.)

Secondary

MeasureTime frameDescription
PTSD Checklist for DSM-5 (PCL-5)12 weeksThe PCL-5 is a validated self-report rating scale for assessing PTSD symptoms. It consists of 20 items that correspond to the DSM-5 symptoms of PTSD. The range is 0-80 with higher scores indicating worse severity.
Symptom Check-List-90-Revised (SCL-90-R)12 weeksThe SCL-90-R is a standard self-report measure of general psychopathology. Each item on the SCL-90-R is graded on a five-point scale from 0 (not at all) to 4 (extremely).The Global Severity Index (GSI) is the average score for all the items and ranges from 0-4 with higher scores indexes greater psychopathology.
Five Facet Mindfulness Questionnaire (FFMQ)- Observing12 weeksThe FFMQ is a 39-item questionnaire derived from a factor analysis of other mindfulness questionnaires. It assesses five facets of mindfulness: observing, describing, acting with awareness, non-judging and non-reactivity to inner experience which represent elements of mindfulness as it is currently conceptualized. Items are rated on a Likert scale ranging from 1 (never or very rarely true) to 5 (very often or always true). Scale range is 39-195 with higher scores indicating higher mindfulness. Score ranges for five facets are: observing (8-40; describing (8-40), acting with awareness (8-40), non-judging (8-40), and nonreactivity to inner experience (7-35).
Insomnia Severity Index (ISI)12 weeksThe ISI is a self-report measure that is a more specific index of perceived insomnia severity, as compared to the widely used PSQI measure which captures sleep disturbances of all types. The ISI uses a 5-point Likert scale to rate the severity of insomnia symptoms. The total score ranges from 0-28 with higher scores indicating worse insomnia severity.
Pittsburgh Sleep Quality Index (PSQI)12 weeksThis self-report measure provides a subjective assessment of sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances (including nightmares), use of sedative-hypnotics, and daytime energy. The PSQI global score range is 0-21 with higher scores indicating worse sleep quality.
Godin Leisure-Time Exercise Questionnaire12 weeksThe Godin Leisure-Time Exercise Questionnaire is a validated brief inventory assessing sedentary, work, recreational, and aerobic activity in a typical week. The overall score is between zero and 119, and higher GLTEQ scores demonstrate more physical activity.

Countries

United States

Participant flow

Participants by arm

ArmCount
Veterans Group Exercise
Exercise 3 times weekly (for 12 weeks), with each total workout lasting approximately 60 minutes. Integrative Exercise incorporates elements of strength training, flexibility, cardiovascular training, and controlled breathing exercises. Veterans Group Exercise (VGX): Integrative Exercise incorporates elements of strength training, flexibility, cardiovascular training, and controlled breathing exercises.
41
Illness Management and Recovery
Attend 3 health education classes weekly (for 12 weeks), with each class lasting approximately 60 minutes. Illness Management and Recovery is an educational program focused on helping individuals more effectively manage their illnesses to pursue their personal recovery goals. The classes include the following topic areas which have been adapted for use in PTSD: recovery, practical facts about PTSD, stress-vulnerability, building social support, medications for PTSD, drug and alcohol use, reducing relapse, coping with stress, coping with persistent symptoms, getting needs met in the VA healthcare system, and living a healthy lifestyle.
43
Total84

Baseline characteristics

CharacteristicVeterans Group ExerciseIllness Management and RecoveryTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
41 Participants43 Participants84 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants5 Participants14 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
27 Participants32 Participants59 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
5 Participants6 Participants11 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants2 Participants4 Participants
Race (NIH/OMB)
Asian
2 Participants5 Participants7 Participants
Race (NIH/OMB)
Black or African American
12 Participants9 Participants21 Participants
Race (NIH/OMB)
More than one race
7 Participants1 Participants8 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
18 Participants26 Participants44 Participants
Region of Enrollment
United States
41 Participants43 Participants84 Participants
Sex: Female, Male
Female
11 Participants15 Participants26 Participants
Sex: Female, Male
Male
30 Participants28 Participants58 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 410 / 43
other
Total, other adverse events
0 / 410 / 43
serious
Total, serious adverse events
0 / 410 / 43

Outcome results

Primary

Clinician Administered PTSD Scale (CAPS) Score Comparison Between Subjects Randomized to Integrative Exercise Treatment vs. Illness Management and Recovery

The CAPS-5 is a 20 item scale that provides both a dimensional and categorical measure of PTSD. The CAPS-5 items are rated with a single severity score, ranging from 0-80 with higher scores indicating worse severity, that incorporates both frequency and intensity PTSD-related symptoms. In addition to assessing the 20 DSM-5 PTSD symptoms, questions target the onset and duration of symptoms, subjective distress, impact of symptoms on social and occupational functioning, improvement in symptoms since a previous CAPS administration, overall response validity, overall PTSD severity, and specifications for the dissociative subtype (depersonalization and derealization).

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Veterans Group ExerciseClinician Administered PTSD Scale (CAPS) Score Comparison Between Subjects Randomized to Integrative Exercise Treatment vs. Illness Management and Recovery24.4 units on a scaleStandard Deviation 11.1
Illness Management and RecoveryClinician Administered PTSD Scale (CAPS) Score Comparison Between Subjects Randomized to Integrative Exercise Treatment vs. Illness Management and Recovery22.0 units on a scaleStandard Deviation 11.3
Primary

The World Health Organization Quality of Life (WHOQOL-BREF) Score Comparison Between Subjects Randomized to Integrative Exercise Treatment vs. Monitor Only

The WHOQOL-BREF instrument comprises 26 items, which measure the following broad domains: physical health, psychological health, social relationships, and environment. The WHOQOL-BREF is a shorter version of the original WHOQOL-100 instrument and is more convenient for use in large research studies or clinical trials. The Psychological Domain, the investigators' primary outcome, is derived from 6 items which index body image, negative & positive feelings, self-esteem, spirituality, and cognition. Each of the 6 items have 5 response options with higher scores indicating higher psychological health. The mean score of items within each domain is used to calculate the domain score. The domain score is then linearly transformed to scale of 0-100 to enable comparisons between other domains composed of unequal numbers of items. (Skevington et al. Quality of Life Research 13: 299-310, 2004.)

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Veterans Group ExerciseThe World Health Organization Quality of Life (WHOQOL-BREF) Score Comparison Between Subjects Randomized to Integrative Exercise Treatment vs. Monitor Only41.5 units on a scaleStandard Deviation 19.4
Illness Management and RecoveryThe World Health Organization Quality of Life (WHOQOL-BREF) Score Comparison Between Subjects Randomized to Integrative Exercise Treatment vs. Monitor Only45.2 units on a scaleStandard Deviation 16.8
Secondary

Five Facet Mindfulness Questionnaire (FFMQ)- Observing

The FFMQ is a 39-item questionnaire derived from a factor analysis of other mindfulness questionnaires. It assesses five facets of mindfulness: observing, describing, acting with awareness, non-judging and non-reactivity to inner experience which represent elements of mindfulness as it is currently conceptualized. Items are rated on a Likert scale ranging from 1 (never or very rarely true) to 5 (very often or always true). Scale range is 39-195 with higher scores indicating higher mindfulness. Score ranges for five facets are: observing (8-40; describing (8-40), acting with awareness (8-40), non-judging (8-40), and nonreactivity to inner experience (7-35).

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Veterans Group ExerciseFive Facet Mindfulness Questionnaire (FFMQ)- Observing22.2 score on a scaleStandard Deviation 11.4
Illness Management and RecoveryFive Facet Mindfulness Questionnaire (FFMQ)- Observing26.4 score on a scaleStandard Deviation 7.1
Secondary

Godin Leisure-Time Exercise Questionnaire

The Godin Leisure-Time Exercise Questionnaire is a validated brief inventory assessing sedentary, work, recreational, and aerobic activity in a typical week. The overall score is between zero and 119, and higher GLTEQ scores demonstrate more physical activity.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Veterans Group ExerciseGodin Leisure-Time Exercise Questionnaire44.2 score on a scaleStandard Deviation 40.2
Illness Management and RecoveryGodin Leisure-Time Exercise Questionnaire43.8 score on a scaleStandard Deviation 36
Secondary

Insomnia Severity Index (ISI)

The ISI is a self-report measure that is a more specific index of perceived insomnia severity, as compared to the widely used PSQI measure which captures sleep disturbances of all types. The ISI uses a 5-point Likert scale to rate the severity of insomnia symptoms. The total score ranges from 0-28 with higher scores indicating worse insomnia severity.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Veterans Group ExerciseInsomnia Severity Index (ISI)13.6 score on a scaleStandard Deviation 6.8
Illness Management and RecoveryInsomnia Severity Index (ISI)13.2 score on a scaleStandard Deviation 5.4
Secondary

Pittsburgh Sleep Quality Index (PSQI)

This self-report measure provides a subjective assessment of sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances (including nightmares), use of sedative-hypnotics, and daytime energy. The PSQI global score range is 0-21 with higher scores indicating worse sleep quality.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Veterans Group ExercisePittsburgh Sleep Quality Index (PSQI)11.4 score on a scaleStandard Deviation 5.2
Illness Management and RecoveryPittsburgh Sleep Quality Index (PSQI)10.7 score on a scaleStandard Deviation 4.2
Secondary

PTSD Checklist for DSM-5 (PCL-5)

The PCL-5 is a validated self-report rating scale for assessing PTSD symptoms. It consists of 20 items that correspond to the DSM-5 symptoms of PTSD. The range is 0-80 with higher scores indicating worse severity.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Veterans Group ExercisePTSD Checklist for DSM-5 (PCL-5)36.3 score on a scaleStandard Deviation 17.5
Illness Management and RecoveryPTSD Checklist for DSM-5 (PCL-5)39.9 score on a scaleStandard Deviation 15.7
Secondary

Symptom Check-List-90-Revised (SCL-90-R)

The SCL-90-R is a standard self-report measure of general psychopathology. Each item on the SCL-90-R is graded on a five-point scale from 0 (not at all) to 4 (extremely).The Global Severity Index (GSI) is the average score for all the items and ranges from 0-4 with higher scores indexes greater psychopathology.

Time frame: 12 weeks

ArmMeasureValue (MEAN)Dispersion
Veterans Group ExerciseSymptom Check-List-90-Revised (SCL-90-R)1.14 score on a scaleStandard Deviation 0.68
Illness Management and RecoverySymptom Check-List-90-Revised (SCL-90-R)1.13 score on a scaleStandard Deviation 0.57

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026